AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Glimzab M 2mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Neucure Lifesciences Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimzab M 2mg/500mg Tablet PR

DiaBeta-Duo 2mg/500mg tablets are classified as anti-diabetic medications, combining two agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. DiaBeta-Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including dietary modifications, regular exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. DiaBeta-Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is vital, and your physician may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimzab M 2mg/500mg Tablet PR

There is no text provided to rephrase.

Uses of Glimzab M 2mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Glimzab M 2mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for dosage guidance. Administer Glimzab M 2mg/500mg Tablet PR with a meal.

Common Side effects of Glimzab M 2mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimzab M 2mg/500mg Tablet PR:

Follow your doctor's instructions or refer to the package insert for dosage information. Administer Glimzab M 2mg/500mg Tablet PR with a meal.

How Glimzab M 2mg/500mg Tablet PR works:

Glimzab M 2mg/500mg tablets are a dual-action antidiabetic formulation containing glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, impeding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimzab M 2mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimzab M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Patient consultation with their doctor is recommended.

Breast feedingBreast feedingUNSAFE

The combination medication Glimzab M (2mg/500mg) is contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Caution is advised when prescribing Glimzab M 2mg/500mg Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not use Glimzab M 2mg/500mg Tablet PR. Physician consultation is recommended. Routine monitoring of kidney function is prudent during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Glimzab M 2mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate hepatic dysfunction, Glimzab M 2mg/500mg Tablet PR is typically initiated at a reduced dose; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glimzab M 2mg/500mg Tablet PR :

Should you forget a Glimzab M 2mg/500mg Tablet PR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimzab M 2mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glimzab M 2mg/500mg Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimzab M 2mg/500mg Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention, including discontinuing Glimzab M, if you experience these symptoms.
Glimzab M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimzab M 2mg/500mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Glimzab M 2mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Glimzab M 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimzab M 2mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimzab M 2mg/500mg Table...
207
MRP 240
13% off